Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Sullivan GC[au]:

Chylothorax. Merrigan BA et al. Br J Surg. (1997)

Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience. Bourke MG et al. Breast Cancer Res Treat. (2017)

Preclinical evaluation of an endoscopic electroporation system. Forde PF et al. Endoscopy. (2016)

Search results

Items: 1 to 50 of 177

1.

Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience.

Bourke MG, Salwa SP, Sadadcharam M, Whelan MC, Forde PF, Larkin JO, Collins CG, O'Reilly S, O'Sullivan GC, Clover AJ, Soden DM.

Breast Cancer Res Treat. 2017 Jan;161(2):289-297. doi: 10.1007/s10549-016-4046-y. Epub 2016 Nov 22.

PMID:
27878392
2.

Preclinical evaluation of an endoscopic electroporation system.

Forde PF, Sadadcharam M, Bourke MG, Conway TA, Guerin SR, de Kruijf M, O'Sullivan GC, Impellizeri J, Clover AJ, Soden DM.

Endoscopy. 2016 May;48(5):477-83. doi: 10.1055/s-0042-101343. Epub 2016 Apr 4.

PMID:
27042930
3.

LC3B globular structures correlate with survival in esophageal adenocarcinoma.

El-Mashed S, O'Donovan TR, Kay EW, Abdallah AR, Cathcart MC, O'Sullivan J, O'Grady A, Reynolds J, O'Reilly S, O'Sullivan GC, McKenna SL.

BMC Cancer. 2015 Aug 12;15:582. doi: 10.1186/s12885-015-1574-5.

4.

Lithium Modulates Autophagy in Esophageal and Colorectal Cancer Cells and Enhances the Efficacy of Therapeutic Agents In Vitro and In Vivo.

O'Donovan TR, Rajendran S, O'Reilly S, O'Sullivan GC, McKenna SL.

PLoS One. 2015 Aug 6;10(8):e0134676. doi: 10.1371/journal.pone.0134676. eCollection 2015.

5.

Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance.

Ryan P, Furlong H, Murphy CG, O'Sullivan F, Walsh TN, Shanahan F, O'Sullivan GC.

Cancer Med. 2015 Aug;4(8):1281-8. doi: 10.1002/cam4.470. Epub 2015 Apr 27.

6.

Oral tolerance to cancer can be abrogated by T regulatory cell inhibition.

Whelan MC, Casey G, Larkin JO, Guinn BA, O'Sullivan GC, Tangney M.

PLoS One. 2014 May 15;9(5):e97602. doi: 10.1371/journal.pone.0097602. eCollection 2014.

7.

An objective evaluation of a multi-component, competitive, selection process for admitting surgeons into higher surgical training in a national setting.

Gallagher AG, O'Sullivan GC, Neary PC, Carroll SM, Leonard G, Bunting BP, Traynor O.

World J Surg. 2014 Feb;38(2):296-304. doi: 10.1007/s00268-013-2302-4.

PMID:
24146198
8.

Attentional capacity: an essential aspect of surgeon performance.

Gallagher AG, Satava RM, OʼSullivan GC.

Ann Surg. 2015 Mar;261(3):e60-1. doi: 10.1097/SLA.0b013e318296c473. No abstract available.

PMID:
23732269
9.

Adenovirus-mediated transcriptional targeting of colorectal cancer and effects on treatment-resistant hypoxic cells.

Rajendran S, O'Sullivan GC, O'Hanlon D, Tangney M.

Clin Colorectal Cancer. 2013 Sep;12(3):152-162.e1. doi: 10.1016/j.clcc.2012.11.005. Epub 2013 Jan 10.

PMID:
23313233
10.

Objective structured assessment of technical skills and checklist scales reliability compared for high stakes assessments.

Gallagher AG, O'Sullivan GC, Leonard G, Bunting BP, McGlade KJ.

ANZ J Surg. 2014 Jul-Aug;84(7-8):568-73. doi: 10.1111/j.1445-2197.2012.06236.x. Epub 2012 Sep 3.

PMID:
22943748
11.

Laparoscopic lavage for perforated diverticulitis: a population analysis.

Rogers AC, Collins D, O'Sullivan GC, Winter DC.

Dis Colon Rectum. 2012 Sep;55(9):932-8. doi: 10.1097/DCR.0b013e31826178d0.

PMID:
22874599
12.

Control and augmentation of long-term plasmid transgene expression in vivo in murine muscle tissue and ex vivo in patient mesenchymal tissue.

Morrissey D, van Pijkeren JP, Rajendran S, Collins SA, Casey G, O'Sullivan GC, Tangney M.

J Biomed Biotechnol. 2012;2012:379845. doi: 10.1155/2012/379845. Epub 2012 Jul 1.

13.

Prospective, randomized assessment of the acquisition, maintenance, and loss of laparoscopic skills.

Gallagher AG, Jordan-Black JA, O'Sullivan GC.

Ann Surg. 2012 Aug;256(2):387-93. doi: 10.1097/SLA.0b013e318251f3d2.

PMID:
22580935
14.

High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting.

Cronin M, Akin AR, Collins SA, Meganck J, Kim JB, Baban CK, Joyce SA, van Dam GM, Zhang N, van Sinderen D, O'Sullivan GC, Kasahara N, Gahan CG, Francis KP, Tangney M.

PLoS One. 2012;7(1):e30940. doi: 10.1371/journal.pone.0030940. Epub 2012 Jan 25.

15.

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells.

Nyhan MJ, O'Donovan TR, Elzinga B, Crowley LC, O'Sullivan GC, McKenna SL.

Br J Cancer. 2012 Feb 14;106(4):711-8. doi: 10.1038/bjc.2011.604. Epub 2012 Jan 12.

16.

Deficits in surgical technical performance: prolonged effects of alcohol.

O'Sullivan GC, Kearney PP, Lönn L, McGlade K.

Arch Surg. 2011 Dec;146(12):1452. doi: 10.1001/archsurg.2011.999. No abstract available.

PMID:
22184315
17.

Targeting regulatory T cells in cancer.

Byrne WL, Mills KH, Lederer JA, O'Sullivan GC.

Cancer Res. 2011 Nov 15;71(22):6915-20. doi: 10.1158/0008-5472.CAN-11-1156. Epub 2011 Nov 8. Review.

18.

Induction of effective antitumor response after mucosal bacterial vector mediated DNA vaccination with endogenous prostate cancer specific antigen.

Ahmad S, Casey G, Cronin M, Rajendran S, Sweeney P, Tangney M, O'Sullivan GC.

J Urol. 2011 Aug;186(2):687-93. doi: 10.1016/j.juro.2011.03.139. Epub 2011 Jun 17.

PMID:
21683415
19.

Targeting of breast metastases using a viral gene vector with tumour-selective transcription.

Rajendran S, Collins S, van Pijkeren JP, O'Hanlon D, O'Sullivan GC, Tangney M.

Anticancer Res. 2011 May;31(5):1627-35.

PMID:
21617219
20.

VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin.

Nyhan MJ, El Mashad SM, O'Donovan TR, Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC, McKenna SL.

Cell Oncol (Dordr). 2011 Jun;34(3):225-34. doi: 10.1007/s13402-011-0029-5. Epub 2011 May 6.

PMID:
21547579
21.

Bacteria as vectors for gene therapy of cancer.

Baban CK, Cronin M, O'Hanlon D, O'Sullivan GC, Tangney M.

Bioeng Bugs. 2010 Nov-Dec;1(6):385-94. doi: 10.4161/bbug.1.6.13146. Review.

22.

Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.

Rajendran S, O'Hanlon D, Morrissey D, O'Donovan T, O'Sullivan GC, Tangney M.

Exp Biol Med (Maywood). 2011 Apr 1;236(4):423-34. doi: 10.1258/ebm.2011.010234. Epub 2011 Mar 28.

PMID:
21444371
23.

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Guo J, Bourre L, Soden DM, O'Sullivan GC, O'Driscoll C.

Biotechnol Adv. 2011 Jul-Aug;29(4):402-17. doi: 10.1016/j.biotechadv.2011.03.003. Epub 2011 Mar 22. Review.

PMID:
21435387
24.

Ex vivo culture of patient tissue & examination of gene delivery.

Rajendran S, Salwa S, Gao X, Tabirca S, O'Hanlon D, O'Sullivan GC, Tangney M.

J Vis Exp. 2010 Dec 20;(46). pii: 2378. doi: 10.3791/2378.

25.
26.

The emerging role of viruses in the treatment of solid tumours.

Bourke MG, Salwa S, Harrington KJ, Kucharczyk MJ, Forde PF, de Kruijf M, Soden D, Tangney M, Collins JK, O'Sullivan GC.

Cancer Treat Rev. 2011 Dec;37(8):618-32. doi: 10.1016/j.ctrv.2010.12.003. Epub 2011 Jan 12. Review.

PMID:
21232872
27.

AAV2-mediated in vivo immune gene therapy of solid tumours.

Collins SA, Buhles A, Scallan MF, Harrison PT, O'Hanlon DM, O'Sullivan GC, Tangney M.

Genet Vaccines Ther. 2010 Dec 20;8:8. doi: 10.1186/1479-0556-8-8.

28.

Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment.

Crowley LC, Elzinga BM, O'Sullivan GC, McKenna SL.

Am J Hematol. 2011 Jan;86(1):38-47. doi: 10.1002/ajh.21914.

29.

Advancing surgical research in a sea of complexity.

O'Sullivan GC.

Ann Surg. 2010 Nov;252(5):711-4. doi: 10.1097/SLA.0b013e3181f98773. No abstract available.

PMID:
21037425
30.

VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin.

Nyhan MJ, El Mashad SM, O'Donovan TR, Ahmad S, Collins C, Sweeney P, Rogers E, O'Sullivan GC, McKenna SL.

Anal Cell Pathol (Amst). 2010;33(3):121-32. doi: 10.3233/ACP-CLO-2010-0541.

31.

Murine bioluminescent hepatic tumour model.

Rajendran S, Salwa S, Gao X, Tabirca S, O'Hanlon D, O'Sullivan GC, Tangney M.

J Vis Exp. 2010 Jul 17;(41). pii: 1977. doi: 10.3791/1977.

32.

Gene therapy for prostate cancer.

Tangney M, Ahmad S, Collins SA, O'Sullivan GC.

Postgrad Med. 2010 May;122(3):166-80. doi: 10.3810/pgm.2010.05.2154.

PMID:
20463426
33.

Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.

Cronin M, Morrissey D, Rajendran S, El Mashad SM, van Sinderen D, O'Sullivan GC, Tangney M.

Mol Ther. 2010 Jul;18(7):1397-407. doi: 10.1038/mt.2010.59. Epub 2010 Apr 13.

34.

Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.

Whelan MC, Casey G, MacConmara M, Lederer JA, Soden D, Collins JK, Tangney M, O'Sullivan GC.

Cancer Gene Ther. 2010 Jul;17(7):501-11. doi: 10.1038/cgt.2010.8. Epub 2010 Feb 26.

PMID:
20186173
35.

Optimised electroporation mediated DNA vaccination for treatment of prostate cancer.

Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC.

Genet Vaccines Ther. 2010 Feb 5;8(1):1. doi: 10.1186/1479-0556-8-1.

36.

Tumour targeting with systemically administered bacteria.

Morrissey D, O'Sullivan GC, Tangney M.

Curr Gene Ther. 2010 Feb;10(1):3-14. Review.

PMID:
20156191
37.

Sonoporation mediated immunogene therapy of solid tumors.

Casey G, Cashman JP, Morrissey D, Whelan MC, Larkin JO, Soden DM, Tangney M, O'Sullivan GC.

Ultrasound Med Biol. 2010 Mar;36(3):430-40. doi: 10.1016/j.ultrasmedbio.2009.11.005. Epub 2010 Feb 4.

PMID:
20133039
38.

A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy.

van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O'Sullivan GC, Gahan CG, Tangney M.

Hum Gene Ther. 2010 Apr;21(4):405-16. doi: 10.1089/hum.2009.022.

PMID:
20105075
39.

International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, Ireland.

Guinn B, Casey G, Möller MG, Kasahara N, O'Sullivan GC, Peng KW, Tangney M.

Hum Gene Ther. 2010 Jan;21(1):9-26. doi: 10.1089/hum.2009.205.

PMID:
20017714
40.

Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.

Möller MG, Salwa S, Soden DM, O'Sullivan GC.

Expert Rev Anticancer Ther. 2009 Nov;9(11):1611-30. doi: 10.1586/era.09.129. Review.

PMID:
19895245
41.

Curcumin induces apoptosis-independent death in oesophageal cancer cells.

O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K, McKenna SL.

Br J Cancer. 2009 Nov 3;101(9):1585-95. doi: 10.1038/sj.bjc.6605308. Epub 2009 Oct 6.

42.

Electroporation of RNA stimulates immunity to an encoded reporter gene in mice.

Piggott JM, Sheahan BJ, Soden DM, O'Sullivan GC, Atkins GJ.

Mol Med Rep. 2009 Sep-Oct;2(5):753-6. doi: 10.3892/mmr_00000168.

PMID:
21475897
43.

Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.

Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC.

Mol Ther. 2009 Jun;17(6):1101-8. doi: 10.1038/mt.2009.66. Epub 2009 Mar 31.

44.

Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours.

Buhles A, Collins SA, van Pijkeren JP, Rajendran S, Miles M, O'Sullivan GC, O'Hanlon DM, Tangney M.

Genet Vaccines Ther. 2009 Mar 9;7:5. doi: 10.1186/1479-0556-7-5.

45.

Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor.

Nyhan MJ, O'Sullivan GC, McKenna SL.

Biochem Soc Trans. 2008 Jun;36(Pt 3):472-8. doi: 10.1042/BST0360472. Review.

PMID:
18481984
46.

Viral vectors in cancer immunotherapy: which vector for which strategy?

Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M.

Curr Gene Ther. 2008 Apr;8(2):66-78. Review.

PMID:
18393828
47.

Electrochemotherapy: an emerging cancer treatment.

Sadadcharam M, Soden DM, O'sullivan GC.

Int J Hyperthermia. 2008 May;24(3):263-73. doi: 10.1080/02656730701832334. Review. Erratum in: Int J Hyperthermia. 2008 May;24(3):273.

PMID:
18393004
48.

Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis.

Scanlan PD, Shanahan F, Clune Y, Collins JK, O'Sullivan GC, O'Riordan M, Holmes E, Wang Y, Marchesi JR.

Environ Microbiol. 2008 Mar;10(3):789-98. doi: 10.1111/j.1462-2920.2007.01503.x. Erratum in: Environ Microbiol. 2008 May;10(5):1382.

PMID:
18237311
49.

Immune gene therapy as a neoadjuvant to surgical excision to control metastatic cancers.

Cashman JP, Larkin JO, Casey G, Whelan MC, Collins C, Aarons S, Tangney M, O'Sullivan GC.

Cancer Lett. 2008 Apr 8;262(1):94-102. doi: 10.1016/j.canlet.2007.11.042. Epub 2008 Jan 7.

PMID:
18179863
50.

Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis.

Myers E, Hurley M, O'Sullivan GC, Kavanagh D, Wilson I, Winter DC.

Br J Surg. 2008 Jan;95(1):97-101.

PMID:
18076019

Supplemental Content

Loading ...
Support Center